HLS Healius Ltd
- 1.455
- -0.030-2.02%
Healius Ltd News
Is It Time to Buy FY24's Worst-performing ASX Shares?
With the end of a financial year and the beginning of a new one this week, it's pertinent to look back on some of our share market's best and worst stocks over the past 12 months and assess whether we should buy these ASX shares.
How ASX Shares Vs. Property Performed in June
That was the 17th consecutive month of growth for the national median price.
Healius Price Target Cut 3% to A$1.28/Share by Morgans
Healius Price Target Cut 3% to A$1.28/Share by Morgans
Jarden Research Adjusts Healius' Price Target to AU$1.22 From AU$1.26, Keeps at Underweight
Healius (ASX:HLS) has an average rating of underperform and price targets ranging from AU$0.09 to AU$3, according to analysts polled by CapitalIQ. Price (AUD): $1.45, Change: $-0.05, Percent Change: -
AU Morning Wrap: Australian Shares Dip Ahead of Inflation Report
Australian shares dip ahead of inflation report. Stocks to watch: Star Entertainment, Healius, Bannerman Energy.
Healius's Struggles Could Continue for While Yet -- Market Talk
2307 GMT - For Healius, things continue to look tough in the near term after the health care company downgraded its FY 2024 earnings guidance due to unexpectedly weak pathology fees, says Jefferies. S
Healius's Lumus Unit Could Fetch Up to A$709 Million -- Market Talk
2300 GMT - Healius's Lumus Imaging division could fetch between A$590 million and A$709 million, Macquarie says. That assumes a sale completes at an FY 2025 Ebitda multiple of 10x-12x. Healius last mo
Healius Price Target Raised 10% to A$1.30/Share by Jefferies
Healius Price Target Raised 10% to A$1.30/Share by Jefferies
Healius Lowers Fiscal 2024 Earnings Guidance
Healius (ASX:HLS) expects fiscal 2024 underlying earnings before interest, taxes, depreciation, and amortization to range between AU$345 million and AU$350 million, according to a Tuesday filing with
AU Morning Wrap: ASX Rises; Paladin Plummets
ASX rises; Paladin plummets. Stocks to watch: Paladin Energy, Healius, Synlait Milk, Coronado Global Resources.
Healius Ltd: Healius announces Trading Update for FY 2024
3 ASX 200 Stocks Leading the Charge Higher in June
Three S&P/ASX 200 Index (ASX: XJO) stocks are doing more than their fair share to get the benchmark index off to a strong start in June.
Healius Hires UBS to Sell Lumus Imaging
Healius (ASX:HLS) has appointed UBS to sell its diagnostic imaging division, Lumus Imaging, as part of a recently completed strategic review, according to a Monday Australian bourse filing. The sale i
Healius Ltd Director's Shareholding Adjustment
Why Fletcher Building, Healius, Iperionx, and Iress Shares Are Sinking Today
The S&P/ASX 200 Index (ASX: XJO) is having a strong session on Wednesday. At the time of writing, the benchmark index is up 0.5% to 7,763.8 points.
Healius's Covenants Suggest Downturn in Operating Conditions -- Market Talk
2321 GMT - Pathology services provider Healius's increase to its near-term loan covenants could suggest operating conditions have worsened, Morgan Stanley says. In a note, analyst Sean Laaman says Hea
Healius Refinances Debt Facility to March 2027
Healius (ASX:HLS) refinanced a tranche of its syndicated debt facility to March 2027. As part of the refinancing, the healthcare company scaled back the demand and the size of the tranche to AU$180 mi
AU Evening Wrap: Australia Shares Rise 0.7%, Led by Real-Estate Stocks
Property trusts were the best performing sector, rising 1.8%.
Healius May Not Get the Strong 4Q It Needs -- Market Talk
2140 GMT - Pathology services provider Healius is banking on a strong 4Q to achieve its earnings guidance, but Jefferies is skeptical it can get there. In a note, analyst David Stanton says Healius's
Healius Price Target Cut 1.7% to A$1.18/Share by Jefferies
Healius Price Target Cut 1.7% to A$1.18/Share by Jefferies
Analysis
Price Target
No Data
